MIFH
RGNX icon

Migdal Insurance & Financial Holdings’s Regenxbio RGNX Stock Holding History

Migdal Insurance & Financial Holdings’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-17,893
Closed -$610K – 660
2021
Q1 		$610K Buy
17,893
+11,104
+164% +$474K 0.01% 299
2020
Q4 		$308K Buy
+6,789
New +$237K ﹤0.01% 257

Other funds holding RGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Migdal Insurance & Financial Holdings's RGNX Position: Q2 2021 in Review

Migdal Insurance & Financial Holdings sold out of Regenxbio (RGNX) in Q2 2021, closing a stake of 17,893 shares — an estimated $610K sold.

Migdal Insurance & Financial Holdings first reported a position in RGNX in Q4 2020 and held it in 2 quarters. The position peaked at $610K in Q1 2021. 172 funds tracked by Wall St. Rank hold RGNX as of Q2 2021.

  • Migdal Insurance & Financial Holdings reported no remaining Regenxbio position as of Q2 2021 after selling out during the quarter.
  • Migdal Insurance & Financial Holdings sold 17,893 Regenxbio shares in Q2 2021, an estimated $610K.
  • Migdal Insurance & Financial Holdings first reported a position in Regenxbio in Q4 2020 and held it in 2 quarters.
  • Migdal Insurance & Financial Holdings's Regenxbio position peaked at $610K in Q1 2021.
  • 172 funds tracked by Wall St. Rank held Regenxbio as of Q2 2021.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q2 2021, filed 4 Aug 2021.